Investigating cardiac energetics in heart failure

Experimental Physiology

Volumn 98, Issue 3, 2013, Pages 601-605

  Lygate, Craig A ^a   Schneider, Jürgen E ^a   Neubauer, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE;

ARTICLE; CREATINE KINASE BLOOD LEVEL; DOWN REGULATION; ELECTROCARDIOGRAM; ENERGY YIELD; HEART FAILURE; HEART FUNCTION; HUMAN; IN VIVO STUDY; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84874075155     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2012.064709     Document Type: Article

References (26)

1. Bakermans AJ, Geraedts TR, van Weeghel M, Denis S, João Ferraz M, Aerts JMFG, Aten J, Nicolay K, Houten SM & Prompers JJ (2011). Fasting-induced myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice is accompanied by impaired left ventricular function. Circ Cardiovasc Imaging 4, 558-565.
2. Chacko VP, Aresta F, Chacko SM & Weiss RG (2000). MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates. Am J Physiol Heart Circ Physiol 279, H2218-H2224.
3. Flogel U, Jacoby C, Godecke A & Schrader J (2007). In vivo 2D mapping of impaired murine cardiac energetics in NO-induced heart failure. Magn Reson Med 57, 50-58.
4. Gupta A, Akki A, Wang Y, Leppo MK, Chacko VP, Foster DB, Caceres V, Shi S, Kirk JA, Su J, Lai S, Paolocci N, Steenbergen C, Gerstenblith G & Weiss RG (2012). Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest 122, 291-302.
5. Gupta A, Chacko VP, Schar M, Akki A & Weiss RG (2011). Impaired ATP kinetics in failing in vivo mouse heart. Circ Cardiovasc Imaging 4, 42-50.
6. Hankiewicz JH, Banke NH, Farjah M & Lewandowski ED (2010). Early impairment of transmural principal strains in the left ventricular wall after short-term, high-fat feeding of mice predisposed to cardiac steatosis. Circ Cardiovasc Imaging 3, 710-717.
7. Hirsch GA, Bottomley PA, Gerstenblith G & Weiss RG (2012). Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts. J Am Coll Cardiol 59, 802-808.
8. Houser SR, Margulies KB, Murphy AM, Spinale FG, Francis GS, Prabhu SD, Rockman HA, Kass DA, Molkentin JD, Sussman MA & Koch WJ (2012). Animal models of heart failure. Circ Res 111, 131-150.
9. Ingwall JS & Shen W (1999). The chemistry of ATP in the failing heart - the fundamentals. Heart Fail Rev 4, 221-228.
10. Ingwall JS & Weiss RG (2004). Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95, 135-145.
11. Lygate C (2006). Surgical models of hypertrophy and heart failure: myocardial infarction and transverse aortic constriction. Drug Disc Today Dis Models 3, 283-290.
12. Lygate CA, Bohl S, Ten Hove M, Faller KM, Ostrowski PJ, Zervou S, Medway DJ, Aksentijevic D, Sebag-Montefiore L, Wallis J, Clarke K, Watkins H, Schneider JE & Neubauer S (2012). Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction. Cardiovasc Res, DOI: 10.1093/cvr/cvs1272.
13. Lygate CA, Fischer A, Sebag-Montefiore L, Wallis J, Ten Hove M & Neubauer S (2007). The creatine kinase energy transport system in the failing mouse heart. J Mol Cell Cardiol 42, 1129-1136.
14. Lygate CA, Schneider JE, Hulbert K, Ten Hove M, Sebag-Montefiore LM, Cassidy PJ, Clarke K & Neubauer S (2006). Serial high resolution 3D-MRI after aortic banding in mice: band internalization is a source of variability in the hypertrophic response. Basic Res Cardiol 101, 8-16.
15. 31P 2D MRS using an actively decoupled coil setup for metabolic phenotyping in mice. Proc Intl Soc Mag Reson Med 17, 1785.
16. Mohammed SF, Storlie JR, Oehler EA, Bowen LA, Korinek J, Lam CS, Simari RD, Burnett JC Jr. & Redfield MM (2012). Variable phenotype in murine transverse aortic constriction. Cardiovasc Pathol 21, 188-198.
17. 31P NMR spectroscopy. Am J Physiol Heart Circ Physiol 285, H1976-H1979.
18. Neubauer S (2007). The failing heart-an engine out of fuel. New Engl J Med 356, 1140-1151.
19. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS & Kochsiek K (1997). Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96, 2190-2196.
20. Phillips D, ten Hove M, Schneider JE, Wu CO, Sebag-Montefiore L, Aponte AM, Lygate CA, Wallis J, Clarke K, Watkins H, Balaban RS & Neubauer S (2010). Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity. J Mol Cell Cardiol 48, 582-590.
21. Schneider JE, Tyler DJ, ten Hove M, Sang AE, Cassidy PJ, Fischer A, Wallis J, Sebag-Montefiore LM, Watkins H, Isbrandt D, Clarke K & Neubauer S (2004). In vivo cardiac 1H-MRS in the mouse. Magn Reson Med 52, 1029-1035.
22. Shen W, Asai K, Uechi M, Mathier MA, Shannon RP, Vatner SF & Ingwall JS (1999). Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation 100, 2113-2118.
23. ten Hove M, Lygate CA, Fischer A, Schneider JE, Sang AE, Hulbert K, Sebag-Montefiore L, Watkins H, Clarke K, Isbrandt D, Wallis J & Neubauer S (2005). Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation 111, 2477-2485.
24. 2+ handling contributes to decreased contractile reserve in rat hearts. Am J Physiol Heart Circ Physiol 275, H2064-H2071.
25. Tian R, Nascimben L, Kaddurah-Daouk R & Ingwall JS (1996). Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol 28, 755-765.
26. Wallis J, Lygate CA, Fischer A, ten Hove M, Schneider JE, Sebag-Montefiore L, Dawson D, Hulbert K, Zhang W, Zhang MH, Watkins H, Clarke K & Neubauer S (2005). Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice. Circulation 112, 3131-3139.